Ingredion posts Q3 2026 earnings below plan amid slower recovery
Ingredion reported Q3 revenue and earnings declines due to slower recovery at Argo and higher costs, leading to downward changes in full-year guidance. The company also noted progress integrating Tate & Lyle.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed